NLRP3 and systemic lupus erythematosus: Therefore, this review will discuss recent evidence of genetic susceptibility of NLRP3 polymorphism in SLE and LN patients, functional studies of NLRP3 activation in cellular and animal models, and possible therapeutic inhibitors of the NLRP3 inflammasome in LN.